Sponsor content
847 result(s) found, displaying 321 to 330
-
Prescription medicine registrationActive ingredients: Salmeterol xinafoate, Fluticasone propionate.
-
Prescription medicine decision summaryTGA decision: Ciptunec Ardalicip (adalimumab) is approved to treat arthritis.
-
Prescription medicine decision summaryTGA decision: Filpegla (pegfilgrastim) is approved for the treatment of cancer patients following chemotherapy.
-
Prescription medicine registrationActive ingredients: Adalimumab.
-
Prescription medicine registrationActive ingredients: Pegfilgrastim.
-
Prescription medicine decision summaryTGA decision: Trastucip and Tuzucip (trastuzumab) are approved to treat breast cancer.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for TENVIR EMTRI 300/200 Tenofovir disoproxil fumarate 300 mg and emtricitabine 200 mg tablet bottle pack.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for CIPLA TENOFOVIR + EMTRICITABINE 300/200 Tenofovir disoproxil fumarate 300 mg and emtricitabine 200 mg tablet bottle pack.
-
Prescription medicine registrationActive ingredients: Trastuzumab.
-
Cancellation by sponsorRequested by Cipla Australia Pty Ltd